Get started
jellow32j

GSK - Zantac - Haleon Mess

Short
GSK plc (NYSE:GSK)  
jellow32j Updated   
NYSE:GSK   GSK plc
Fundamental Analysis Trend Analysis
1
0
fundamental trendanalysis
GSK technically at Jan 1992 Support/Resistance level.

On news of the Zantac issue.

This presents what could be a descending triangle pattern.

Will they be able to walk away from this horrible situation (for those that have consumed the original Zantac there are no words to describe)?
Comment:
GSK has bounded for now off of support.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.